MedaSense Biometrics Ltd – Booth #209
The PMD-200 is the first and only monitor to be FDA-authorized for monitoring pain in anesthetized patients. The PMD-200 with NOL technology is the only technology using innovative AI machine learning algorithms to assess the continuous streams of physiological information using a finger probe, providing a robust, personalized index assessing the patient’s nociception/analgesia balance.